Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Keks

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Clinical Therapeutics|January 1, 1997
Impact of newer antipsychotics on outcomes in schizophreniaN A Keks
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|November 4, 1998
[Use of novel agents in the treatment of schizophrenia and a look to the future]N A Keks
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1996
Minimizing the non-extrapyramidal side-effects of antipsychoticsN A Keks
The Medical Journal of Australia|May 20, 1996
Schizophrenia and the communityN A Keks, T Sacks
Expert Opinion on Investigational Drugs|July 5, 2005
Risperidone (Risperdal): clinical experience with a new antipsychosis drugN A Keks, C Culhane
The Medical Journal of Australia|July 17, 1995
Use of psychotropic drugs in the communityN A Keks, G D Burrows
The Medical Journal of Australia|January 17, 1994
New medications for the schizophreniasN A Keks, G D Burrows
The Medical Journal of Australia|May 2, 1994
Withdrawal of remoxiprideN A Keks, G D Burrows
The Medical Journal of Australia|August 4, 1997
The essential practice of mental health careN A Keks, G D Burrows
The Medical Journal of Australia|May 13, 1998
Alcohol and drug dependence: diagnosis and managementT L Sacks, N A Keks
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Clinical Therapeutics|January 1, 1997
Impact of newer antipsychotics on outcomes in schizophreniaN A Keks
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|November 4, 1998
[Use of novel agents in the treatment of schizophrenia and a look to the future]N A Keks
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1996
Minimizing the non-extrapyramidal side-effects of antipsychoticsN A Keks
The Medical Journal of Australia|May 20, 1996
Schizophrenia and the communityN A Keks, T Sacks
Expert Opinion on Investigational Drugs|July 5, 2005
Risperidone (Risperdal): clinical experience with a new antipsychosis drugN A Keks, C Culhane
The Medical Journal of Australia|July 17, 1995
Use of psychotropic drugs in the communityN A Keks, G D Burrows
The Medical Journal of Australia|January 17, 1994
New medications for the schizophreniasN A Keks, G D Burrows
The Medical Journal of Australia|May 2, 1994
Withdrawal of remoxiprideN A Keks, G D Burrows
The Medical Journal of Australia|August 4, 1997
The essential practice of mental health careN A Keks, G D Burrows
The Medical Journal of Australia|May 13, 1998
Alcohol and drug dependence: diagnosis and managementT L Sacks, N A Keks
Pageof 3